APX-007 (Apexigen/Epitomics)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAPX-007 (Apexigen/Epitomics)
Drug Alias Nameanti-interleukin-6 receptor monoclonal antibodies - Apexigen/EpitomicsAPX-007
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionInterleukin-6 receptor alpha subunit antagonists
TargetsInterleukin-6 receptor alpha subunit
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEpitomics IncApexigen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEpitomics IncApexigen Inc
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A